Navigation Links
Enzyme may hold key to improved targeting of cancer-fighting drugs
Date:5/29/2008

CHESTNUT HILL, MA A critical enzyme used to prepare a powerful cancer-killing agent may be able to help drug makers better target the cells the natural product attacks, according to findings published in the May 23 edition of the Journal of Biological Chemistry.

Building on their earlier research into neocarzinostatin, a team of researchers from Boston College and the University of Wisconsin, Madison discovered that one of the enzymes contained in the bacteria used to produce the drug may hold promise in creating newer, more stable compounds from the structurally complex class of antibiotic known as chromoproteins.

"We've revealed that the enzyme is loose in specificity, which means it may be able to be used to make new drugs," said Boston College Chemist Steven D. Bruner, a co-author of the report. "Based on these findings, we foresee success in the lab making certain compounds more controllable."

In addition to Bruner, the research team includes BC graduate student Heather A. Cooke and University of Wisconsin Professor Ben Shen and researchers Yinggang Luo, Shuangjun Lin and Jian Zhang.

Used as a chemotherapeutic, the drug an enediyne anti-tumor agent targets both normal and cancer cells, says Bruner, an assistant professor of chemistry. But the team has determined that the chemical components of the antibiotic are capable of distinguishing between normal cells and cancer cells.

The latest research confirmed the team's proposal that the naphthoic acid within the compound can be altered to design cancer-fighting drugs specific to chemotherapeutic targets. That will require the use of genetic engineering in order to manipulate the molecules within the bacteria, which occurs naturally in soil.

Genetic engineering will enable researchers to produce more specific and less toxic analogs of neocarzinostatin and increase the available supply of the drug, Bruner says.

"This is the beginning of an approa
'/>"/>

Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
3. Scientists reveal DNA-enzyme interaction with first ever real time footage
4. UCSD study reveals the regulatory mechanism of key enzyme
5. UCSD study reveals the regulatory mechanism of key enzyme
6. Enzymes second messenger contributes to cell overgrowth
7. Delaware Court Approves Bioenvision, Genzyme Joint Petition
8. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
9. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
10. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
11. Role of a key enzyme in reducing heart disease identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... April 25, 2015 Gardant Management ... wellness, management and operations, and sales and marketing ... Exhibition scheduled to be held from April 29 ... Illinois is the largest eldercare association in Illinois. ... services for older adults, including senior housing, assisted ...
(Date:4/25/2015)... Minneapolis, Minnesota (PRWEB) April 25, 2015 For ... as the premier income protection education event in the nation! ... up with The Plus Group, US to take DI Day ... Day. , George G. Davidson, CLU, ChFC, RHU, DIA, CLTC, ... Twin Cities DI Day reflects on the change by stating, ...
(Date:4/24/2015)... 2015 Ryadon is a leading manufacturer ... capabilities and services to complement any custom hardware requirements ... Program will be offered on all heavy duty drawer ... Receive 10% discount - Order 20+: Receive 20% discount ... Slides Products, Furniture ,Drawer ...
(Date:4/24/2015)... CA (PRWEB) April 24, 2015 On ... sitting down in an interview with ItsNotAboutMe.TV contributor Karen ... Recovery, a holistic treatment center for addiction, of which ... ceremonies and festivals throughout the year, the EcoLuxe Lounge ... providers of eco-friendly and socially conscious products and services. ...
(Date:4/24/2015)... Integrative Therapeutics has introduced two new ... cognition. , A unique combination of herbs and ... Flavonoid Complex apart from other antioxidant supplements. This ... support antioxidation versus the use of single or ... extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 with ...
Breaking Medicine News(10 mins):Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Secura Consultants Takes DI Day On The Road 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Karen Salkin Talks with Per Wickstrom at the 2015 EcoLuxe Lounge and the "Salute to the Oscars" Celebration 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4
... 9 Volcano Corporation,(Nasdaq: VOLC ) announced today ... the third quarter ended September 30, 2007.,The company said ... increase in the sales of its Intravascular Ultrasound (IVUS),disposables ... of,24 percent in sales of IVUS disposables versus the ...
... COLORADO SPRINGS, Colo., Oct. 9 Spectranetics,Corporation (Nasdaq: ... reimbursement,approval from the competent governmental authority in Belgium ... effective October 1, 2007. The reimbursement for ... or an electronic malfunction of a pacemaker or ...
... Natural Nutrition,(OTC Bulletin Board: NNTN) http://www.interactivenutrition.com ... 11, 2007 at,11:00 a.m. Eastern time. U.S. and ... at 800-750-4065 and International Shareholders may dial in ... is 767872#. Executives,from Natural Nutrition will be available ...
... 9 Endocare, Inc. (OTC,Bulletin Board: ECRE), an ... minimally invasive technologies for tissue and tumor,ablation, announced ... on NASDAQ.,The Company,s common stock will commence trading ... beginning tomorrow, October 10, 2007. Craig T. ...
... Oct. 9 Volcano Corporation,(Nasdaq: VOLC ) announced ... to,market and other conditions, 6,000,000 shares of newly issued ... filed,with the Securities and Exchange Commission. The Company intends ... to an additional 900,000,shares of common stock. J.P. ...
... ... reform, DES MOINES, Iowa, Oct. 9 ... weighed in on a,critical 2008 campaign issue: health care. According to a survey ... current health care system is broken-and they don,t trust,politicians to fix it. ...
Cached Medicine News:Health News:Volcano Corporation Reports Preliminary Third Quarter 2007 Revenues 2Health News:Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products 2Health News:Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products 3Health News:Natural Nutrition to Hold International Shareholder Conference Call Thursday, October 11, 2007 at 11:00 a.m. Eastern Time 2Health News:Endocare Stock to Commence Trading on NASDAQ 2Health News:Volcano Corporation Announces Proposed Public Offering of Common Stock 2Health News:Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward America's Health Care Crisis 2Health News:Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward America's Health Care Crisis 3Health News:Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward America's Health Care Crisis 4
(Date:4/24/2015)... 24, 2015   Bernstein Liebhard LLP ... or the "Company") (NASDAQ: AERI ) issued ... violation of the federal securities laws; or (ii) ... fiduciary duties to shareholders. Aerie is ... development and commercialization of first-in-class therapies for the ...
(Date:4/24/2015)... April 24, 2015 Allowing more basic emergency ... drug overdose deaths that involve opioids, according to a ... in Naloxone Administration by Emergency Medical Service Providers and ... in the American Journal of Public Health . ... the United States involved prescription ...
(Date:4/24/2015)... April 24, 2015  A new study shows an "alarming ... drugs used to slow the progression of multiple sclerosis or ... by researchers at Oregon Health & Science University (OHSU) and ... the number of MS drugs in the marketplace over the ... stabilized costs for patients who use those drugs. Researchers found ...
Breaking Medicine Technology:Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc. 2Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
... 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel's leading drug ... I trial of BL-1020, the first GABA,enhanced ... The trial demonstrated that the compound was ... which is indicative of efficacy. BioLineRx presented ...
... -- Auxilium,Pharmaceuticals, Inc. today announced that new ... energy levels and,erectile function in 76 percent ... replacement gel therapy. Total testosterone,levels increased significantly ... (testosterone gel) following suboptimal,response to Solvay S.A.'s ...
Cached Medicine Technology:BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
Conventional Digitally-Controlled Water Baths...
Conventional Digitally-Controlled Water Baths...
... a flexible, self-expanding nitinol design intended to ... biliary system, is now available from Cook ... and Drug Administration. Incorporating the features that ... successful around the world, the Zilver 518 ...
... The AB5000 Circulatory Support System consists of ... advanced computer system that drives the blood pumps ... or for transport of patients between hospitals. The ... of supporting the left, right, or both ventricles ...
Medicine Products: